We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans

By HospiMedica International staff writers
Posted on 04 Jul 2022

Currently, the diagnosis of COVID-19 is based on nucleic acid testing, or PCR tests as they are commonly known. These tests can produce false negatives and results can also be affected by hysteresis – when the physical effects of an illness lag behind their cause. Artificial intelligence (AI) offers an opportunity to rapidly screen and effectively monitor COVID-19 cases on a large scale, reducing the burden on doctors. Now, researchers have created a new AI tool that can detect COVID-19. The software analyses chest CT scans and uses deep learning algorithms to accurately diagnose the disease. With an accuracy rate of 97.86%, it is currently the most successful COVID-19 diagnostic tool in the world.

Researchers from the University of Leicester (Leicester, UK) who developed the new AI tool will now further develop this technology in the hope that the Covid computer may eventually replace the need for radiologists to diagnose COVID-19 in clinics. The software, which can even be deployed in portable devices such as smart phones, will also be adapted and expanded to detect and diagnose other diseases (such as breast cancer, Alzheimer’s Disease, and cardiovascular diseases).

"Our research focuses on the automatic diagnosis of COVID-19 based on random graph neural network. The results show that our method can find suspicious regions in the chest images automatically and make accurate predictions based on the representations," said Professor Yudong Zhang, Professor of Knowledge Discovery and Machine Learning at the University of Leicester. "The accuracy of the system means that it can be used in the clinical diagnosis of COVID-19, which may help to control the spread of the virus. We hope that, in the future, this type of technology will allow for automated computer diagnosis without the need for manual intervention, in order to create a smarter, efficient healthcare service."

Related Links:
University of Leicester 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair
New
Vital Signs Monitor
iM3s
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel approach utilizes continuous glucose monitoring to detect early signs of impaired glucose regulation (Photo courtesy of Shinya Kuroda/University of Tokyo)

Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk

Diabetes, often referred to as a "silent epidemic," is a growing global health issue with significant impacts on both health and the economy. Detecting impaired glucose regulation early — an intermediate... Read more

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.